Treatment with mTORC1-specific inhibitor rapamycin in murine CD4+ T-cell transfer model of colitis also decreases Th17 differentiation and attenuates the decrease in body weights (Kurebayashi et al. 2012). This evidence concerns the gene CD4 and colitis.